article · International Journal of Mathematics Statistics and Computer Science
Colorectal cancer (CRC) prognosis remains challenging due to the disease's heterogeneity and the complex interplay of clinical, demographic, and molecular factors. This study leverages explainable artificial intelligence (XAI) and electronic health records (EHRs) to develop interpretable machine learning models for prognostic factor identification in CRC. Using a retrospective cohort of 8,247 patients, we extracted 1,247 features from EHRs, including demographic, laboratory, treatment, and natural language processing (NLP)-derived data. After rigorous feature selection, six machine learning models were evaluated, with XGBoost achieving the highest performance (C-index: 0.798, 95% CI: 0.785–0.811), significantly outperforming traditional Cox models (C-index: 0.742) and established prognostic scores. SHAP and LIME analyses identified both established prognostic factors (e.g., TNM stage, age) and novel predictors, such as temporal albumin trends and neutrophil-to-lymphocyte ratio (NLR), which accounted for 40% of the top prognostic features. Clinical validation by oncology experts confirmed the relevance and biological plausibility of these findings. The study demonstrates that XAI-enhanced models can improve prognostic accuracy while providing transparent, actionable insights, bridging the gap between complex machine learning outputs and clinical decision-making. These results highlight the potential of integrating comprehensive EHR data with XAI to advance precision oncology in CRC care.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.59543/ijmscs.v3i.15123
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.